Pityriasis rubra pilaris: failure of combination treatment with acitretin and infliximab.
Lu
Rebecca
R
Department of Dermatology, Baylor College of Medicine, Houston, Texas, USA.
George
Saira J
SJ
Hsu
Sylvia
S
D017255:Acitretin / Q000627:therapeutic use*; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D003879:Dermatologic Agents / Q000627:therapeutic use*; D004351:Drug Resistance; D006801:Humans; D000069285:Infliximab; D007641:Keratolytic Agents / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D010916:Pityriasis Rubra Pilaris / Q000188:drug therapy*; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors
D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal; D003879:Dermatologic Agents; D007641:Keratolytic Agents; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab; D017255:Acitretin